Last update 28 Oct 2025
Synovo GmbH

Synovo GmbH

Private Company|2004|Germany|
< 10
|
synovo.com

Overview

Tags

Immune System Diseases
Infectious Diseases
Small molecule drug
Oligonucleotide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Oligonucleotide1
Top 5 TargetCount
TLR7(Toll like receptor 7)1
JAK3(Tyrosine-protein kinase JAK3)1

Related

2
Drugs associated with Synovo GmbH
WO2024138157
Patent Mining
Target
TLR7
Mechanism-
Active Org.
Synovo GmbHSynovo GmbH
Originator Org.
Synovo GmbHSynovo GmbH
Active Indication
Infectious Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
WO2023248010
Patent Mining
Target
JAK3
Mechanism
JAK3 modulators
Active Org.
Synovo GmbHSynovo GmbH
Originator Org.
Synovo GmbHSynovo GmbH
Active Indication
Autoimmune Diseases
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Synovo GmbH
Login to view more data
0 Patents (Medical) associated with Synovo GmbH
Login to view more data
100 Deals associated with Synovo GmbH
Login to view more data
100 Translational Medicine associated with Synovo GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
WO2024138157
 ( TLR7 )Patent Mining		Infectious Diseases
More
Discovery
WO2023248010
 ( JAK3 )Patent Mining		Autoimmune Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free